nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—SLCO1A2—epilepsy syndrome	0.152	0.461	CbGaD
Probenecid—ABCC2—epilepsy syndrome	0.0725	0.22	CbGaD
Probenecid—CYP2C19—epilepsy syndrome	0.0504	0.153	CbGaD
Probenecid—SLCO1C1—Phenytoin—epilepsy syndrome	0.0347	0.077	CbGbCtD
Probenecid—ALB—epilepsy syndrome	0.028	0.0849	CbGaD
Probenecid—ABCB1—epilepsy syndrome	0.0267	0.0811	CbGaD
Probenecid—SLC16A1—Valproic Acid—epilepsy syndrome	0.0231	0.0513	CbGbCtD
Probenecid—ABCC3—Phenobarbital—epilepsy syndrome	0.0194	0.0432	CbGbCtD
Probenecid—ABCC2—Levetiracetam—epilepsy syndrome	0.0192	0.0427	CbGbCtD
Probenecid—ABCC1—Phenobarbital—epilepsy syndrome	0.0119	0.0265	CbGbCtD
Probenecid—SLC22A7—Valproic Acid—epilepsy syndrome	0.0113	0.0252	CbGbCtD
Probenecid—ABCC2—Carbamazepine—epilepsy syndrome	0.011	0.0245	CbGbCtD
Probenecid—ALB—Oxcarbazepine—epilepsy syndrome	0.011	0.0244	CbGbCtD
Probenecid—ABCC2—Phenytoin—epilepsy syndrome	0.0099	0.022	CbGbCtD
Probenecid—ALB—Fosphenytoin—epilepsy syndrome	0.00958	0.0213	CbGbCtD
Probenecid—SLC22A1—Midazolam—epilepsy syndrome	0.00926	0.0206	CbGbCtD
Probenecid—ABCC2—Phenobarbital—epilepsy syndrome	0.00883	0.0196	CbGbCtD
Probenecid—ALB—Clonazepam—epilepsy syndrome	0.00866	0.0193	CbGbCtD
Probenecid—SLC22A5—Valproic Acid—epilepsy syndrome	0.00847	0.0188	CbGbCtD
Probenecid—CYP2C8—Trimethadione—epilepsy syndrome	0.00787	0.0175	CbGbCtD
Probenecid—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0074	0.0165	CbGbCtD
Probenecid—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0071	0.0158	CbGbCtD
Probenecid—ALB—Rufinamide—epilepsy syndrome	0.00706	0.0157	CbGbCtD
Probenecid—SLC22A8—Valproic Acid—epilepsy syndrome	0.00693	0.0154	CbGbCtD
Probenecid—CYP2C19—Felbamate—epilepsy syndrome	0.0066	0.0147	CbGbCtD
Probenecid—CYP2C19—Trimethadione—epilepsy syndrome	0.0066	0.0147	CbGbCtD
Probenecid—SLC22A6—Acetazolamide—epilepsy syndrome	0.00646	0.0144	CbGbCtD
Probenecid—ABCB1—Levetiracetam—epilepsy syndrome	0.00627	0.0139	CbGbCtD
Probenecid—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00621	0.0138	CbGbCtD
Probenecid—ALB—Phenytoin—epilepsy syndrome	0.00617	0.0137	CbGbCtD
Probenecid—ALB—Propofol—epilepsy syndrome	0.00576	0.0128	CbGbCtD
Probenecid—CYP2C9—Trimethadione—epilepsy syndrome	0.00549	0.0122	CbGbCtD
Probenecid—CYP2C19—Clobazam—epilepsy syndrome	0.00538	0.012	CbGbCtD
Probenecid—CYP2C8—Carbamazepine—epilepsy syndrome	0.00532	0.0118	CbGbCtD
Probenecid—ALB—Diazepam—epilepsy syndrome	0.00522	0.0116	CbGbCtD
Probenecid—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00516	0.0115	CbGbCtD
Probenecid—CYP2C8—Primidone—epilepsy syndrome	0.00496	0.011	CbGbCtD
Probenecid—SLC22A6—Valproic Acid—epilepsy syndrome	0.00483	0.0107	CbGbCtD
Probenecid—CYP2C8—Phenytoin—epilepsy syndrome	0.00477	0.0106	CbGbCtD
Probenecid—CYP2C19—Carbamazepine—epilepsy syndrome	0.00446	0.00991	CbGbCtD
Probenecid—CYP2C8—Propofol—epilepsy syndrome	0.00445	0.00989	CbGbCtD
Probenecid—ABCB1—Clobazam—epilepsy syndrome	0.00434	0.00965	CbGbCtD
Probenecid—CYP2C8—Phenobarbital—epilepsy syndrome	0.00425	0.00945	CbGbCtD
Probenecid—ABCB1—Lamotrigine—epilepsy syndrome	0.00418	0.00929	CbGbCtD
Probenecid—CYP2C19—Primidone—epilepsy syndrome	0.00416	0.00926	CbGbCtD
Probenecid—CYP2C8—Diazepam—epilepsy syndrome	0.00403	0.00896	CbGbCtD
Probenecid—CYP2C19—Phenytoin—epilepsy syndrome	0.004	0.00889	CbGbCtD
Probenecid—CYP2C19—Propofol—epilepsy syndrome	0.00373	0.00829	CbGbCtD
Probenecid—CYP2C9—Carbamazepine—epilepsy syndrome	0.00371	0.00824	CbGbCtD
Probenecid—ABCB1—Carbamazepine—epilepsy syndrome	0.0036	0.008	CbGbCtD
Probenecid—CYP2C19—Phenobarbital—epilepsy syndrome	0.00357	0.00793	CbGbCtD
Probenecid—CYP2C9—Primidone—epilepsy syndrome	0.00346	0.0077	CbGbCtD
Probenecid—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00343	0.00763	CbGbCtD
Probenecid—CYP2C19—Diazepam—epilepsy syndrome	0.00338	0.00751	CbGbCtD
Probenecid—CYP2C9—Phenytoin—epilepsy syndrome	0.00333	0.00739	CbGbCtD
Probenecid—CYP2C19—Zonisamide—epilepsy syndrome	0.0033	0.00733	CbGbCtD
Probenecid—ABCB1—Phenytoin—epilepsy syndrome	0.00323	0.00718	CbGbCtD
Probenecid—CYP3A4—Felbamate—epilepsy syndrome	0.00319	0.0071	CbGbCtD
Probenecid—CYP3A4—Trimethadione—epilepsy syndrome	0.00319	0.0071	CbGbCtD
Probenecid—CYP2C8—Valproic Acid—epilepsy syndrome	0.00318	0.00706	CbGbCtD
Probenecid—CYP2C9—Propofol—epilepsy syndrome	0.0031	0.0069	CbGbCtD
Probenecid—CYP3A4—Fosphenytoin—epilepsy syndrome	0.003	0.00667	CbGbCtD
Probenecid—CYP2C9—Phenobarbital—epilepsy syndrome	0.00297	0.00659	CbGbCtD
Probenecid—ABCB1—Phenobarbital—epilepsy syndrome	0.00288	0.0064	CbGbCtD
Probenecid—ABCB1—Midazolam—epilepsy syndrome	0.00284	0.00631	CbGbCtD
Probenecid—CYP2C9—Diazepam—epilepsy syndrome	0.00281	0.00625	CbGbCtD
Probenecid—ABCB1—Diazepam—epilepsy syndrome	0.00273	0.00606	CbGbCtD
Probenecid—CYP3A4—Clonazepam—epilepsy syndrome	0.00271	0.00603	CbGbCtD
Probenecid—CYP2C19—Valproic Acid—epilepsy syndrome	0.00267	0.00592	CbGbCtD
Probenecid—CYP3A4—Clobazam—epilepsy syndrome	0.0026	0.00578	CbGbCtD
Probenecid—CYP2C19—Topiramate—epilepsy syndrome	0.0024	0.00534	CbGbCtD
Probenecid—CYP2C9—Valproic Acid—epilepsy syndrome	0.00222	0.00492	CbGbCtD
Probenecid—CYP3A4—Rufinamide—epilepsy syndrome	0.00221	0.00492	CbGbCtD
Probenecid—CYP3A4—Carbamazepine—epilepsy syndrome	0.00216	0.00479	CbGbCtD
Probenecid—CYP3A4—Primidone—epilepsy syndrome	0.00201	0.00447	CbGbCtD
Probenecid—CYP3A4—Phenytoin—epilepsy syndrome	0.00193	0.0043	CbGbCtD
Probenecid—CYP3A4—Propofol—epilepsy syndrome	0.0018	0.00401	CbGbCtD
Probenecid—CYP3A4—Acetazolamide—epilepsy syndrome	0.00172	0.00383	CbGbCtD
Probenecid—CYP3A4—Phenobarbital—epilepsy syndrome	0.00172	0.00383	CbGbCtD
Probenecid—CYP3A4—Midazolam—epilepsy syndrome	0.0017	0.00378	CbGbCtD
Probenecid—CYP3A4—Diazepam—epilepsy syndrome	0.00163	0.00363	CbGbCtD
Probenecid—CYP3A4—Zonisamide—epilepsy syndrome	0.0016	0.00355	CbGbCtD
Probenecid—SLCO1C1—ganglion—epilepsy syndrome	0.00131	0.0466	CbGeAlD
Probenecid—CYP3A4—Valproic Acid—epilepsy syndrome	0.00129	0.00286	CbGbCtD
Probenecid—PANX1—forebrain—epilepsy syndrome	0.00117	0.0416	CbGeAlD
Probenecid—CYP3A4—Topiramate—epilepsy syndrome	0.00116	0.00258	CbGbCtD
Probenecid—PANX1—telencephalon—epilepsy syndrome	0.00108	0.0382	CbGeAlD
Probenecid—SLC22A1—ganglion—epilepsy syndrome	0.000783	0.0277	CbGeAlD
Probenecid—PANX1—spinal cord—epilepsy syndrome	0.000756	0.0268	CbGeAlD
Probenecid—PANX1—head—epilepsy syndrome	0.000672	0.0238	CbGeAlD
Probenecid—PANX1—nervous system—epilepsy syndrome	0.000637	0.0226	CbGeAlD
Probenecid—SLC16A7—forebrain—epilepsy syndrome	0.000628	0.0222	CbGeAlD
Probenecid—PANX1—central nervous system—epilepsy syndrome	0.000613	0.0217	CbGeAlD
Probenecid—PANX1—cerebellum—epilepsy syndrome	0.000599	0.0212	CbGeAlD
Probenecid—Procaine—CHRNA2—epilepsy syndrome	0.000585	0.153	CrCbGaD
Probenecid—SLC16A7—telencephalon—epilepsy syndrome	0.000577	0.0205	CbGeAlD
Probenecid—SLCO1C1—forebrain—epilepsy syndrome	0.000551	0.0195	CbGeAlD
Probenecid—SLCO1C1—telencephalon—epilepsy syndrome	0.000507	0.018	CbGeAlD
Probenecid—PANX1—brain—epilepsy syndrome	0.000487	0.0173	CbGeAlD
Probenecid—SLC16A7—medulla oblongata—epilepsy syndrome	0.000454	0.0161	CbGeAlD
Probenecid—SLC16A7—midbrain—epilepsy syndrome	0.000415	0.0147	CbGeAlD
Probenecid—ABCC5—telencephalon—epilepsy syndrome	0.000404	0.0143	CbGeAlD
Probenecid—Procainamide—SCN8A—epilepsy syndrome	0.000391	0.102	CrCbGaD
Probenecid—ABCC6—head—epilepsy syndrome	0.00037	0.0131	CbGeAlD
Probenecid—SLC16A1—telencephalon—epilepsy syndrome	0.000367	0.013	CbGeAlD
Probenecid—SLCO1C1—midbrain—epilepsy syndrome	0.000364	0.0129	CbGeAlD
Probenecid—SLC16A7—head—epilepsy syndrome	0.000359	0.0127	CbGeAlD
Probenecid—SLCO1C1—spinal cord—epilepsy syndrome	0.000355	0.0126	CbGeAlD
Probenecid—SLC16A7—nervous system—epilepsy syndrome	0.000341	0.0121	CbGeAlD
Probenecid—SLC10A1—head—epilepsy syndrome	0.000336	0.0119	CbGeAlD
Probenecid—SLC22A1—forebrain—epilepsy syndrome	0.000329	0.0116	CbGeAlD
Probenecid—SLC16A7—central nervous system—epilepsy syndrome	0.000328	0.0116	CbGeAlD
Probenecid—SLC16A7—cerebellum—epilepsy syndrome	0.000321	0.0114	CbGeAlD
Probenecid—SLC10A1—nervous system—epilepsy syndrome	0.000318	0.0113	CbGeAlD
Probenecid—ABCC5—medulla oblongata—epilepsy syndrome	0.000317	0.0112	CbGeAlD
Probenecid—Procainamide—SCN9A—epilepsy syndrome	0.000317	0.0826	CrCbGaD
Probenecid—SLCO1A2—forebrain—epilepsy syndrome	0.000316	0.0112	CbGeAlD
Probenecid—SLCO1C1—head—epilepsy syndrome	0.000316	0.0112	CbGeAlD
Probenecid—Tolbutamide—SLCO1A2—epilepsy syndrome	0.000308	0.0804	CrCbGaD
Probenecid—SLC10A1—central nervous system—epilepsy syndrome	0.000306	0.0109	CbGeAlD
Probenecid—ABCC4—forebrain—epilepsy syndrome	0.000304	0.0108	CbGeAlD
Probenecid—Procainamide—SCN3A—epilepsy syndrome	0.000303	0.079	CrCbGaD
Probenecid—SLC22A1—telencephalon—epilepsy syndrome	0.000302	0.0107	CbGeAlD
Probenecid—SLCO1C1—nervous system—epilepsy syndrome	0.000299	0.0106	CbGeAlD
Probenecid—Procainamide—SCN4A—epilepsy syndrome	0.000291	0.0759	CrCbGaD
Probenecid—SLCO1A2—telencephalon—epilepsy syndrome	0.000291	0.0103	CbGeAlD
Probenecid—ABCC5—midbrain—epilepsy syndrome	0.00029	0.0103	CbGeAlD
Probenecid—SLC16A1—medulla oblongata—epilepsy syndrome	0.000289	0.0102	CbGeAlD
Probenecid—SLCO1C1—central nervous system—epilepsy syndrome	0.000288	0.0102	CbGeAlD
Probenecid—Chlorpropamide—KCNJ11—epilepsy syndrome	0.00028	0.073	CrCbGaD
Probenecid—Tolbutamide—KCNJ11—epilepsy syndrome	0.000273	0.0711	CrCbGaD
Probenecid—SLC16A1—midbrain—epilepsy syndrome	0.000264	0.00935	CbGeAlD
Probenecid—SLC16A7—brain—epilepsy syndrome	0.00026	0.00923	CbGeAlD
Probenecid—SLC16A1—spinal cord—epilepsy syndrome	0.000257	0.00912	CbGeAlD
Probenecid—SLC10A1—brain—epilepsy syndrome	0.000243	0.00862	CbGeAlD
Probenecid—ABCC1—telencephalon—epilepsy syndrome	0.000239	0.00846	CbGeAlD
Probenecid—SLC16A1—head—epilepsy syndrome	0.000229	0.00811	CbGeAlD
Probenecid—SLCO1C1—brain—epilepsy syndrome	0.000229	0.0081	CbGeAlD
Probenecid—SLCO1A2—medulla oblongata—epilepsy syndrome	0.000229	0.0081	CbGeAlD
Probenecid—ABCC5—cerebellum—epilepsy syndrome	0.000224	0.00795	CbGeAlD
Probenecid—SLC16A1—nervous system—epilepsy syndrome	0.000217	0.00769	CbGeAlD
Probenecid—SLC22A7—brain—epilepsy syndrome	0.000217	0.00768	CbGeAlD
Probenecid—Procainamide—SCN1A—epilepsy syndrome	0.000213	0.0555	CrCbGaD
Probenecid—ABCC3—head—epilepsy syndrome	0.000211	0.00748	CbGeAlD
Probenecid—SLC22A6—brain—epilepsy syndrome	0.000209	0.00742	CbGeAlD
Probenecid—SLCO1A2—midbrain—epilepsy syndrome	0.000209	0.0074	CbGeAlD
Probenecid—SLC16A1—central nervous system—epilepsy syndrome	0.000209	0.0074	CbGeAlD
Probenecid—SLC16A1—cerebellum—epilepsy syndrome	0.000204	0.00723	CbGeAlD
Probenecid—SLCO1A2—spinal cord—epilepsy syndrome	0.000204	0.00722	CbGeAlD
Probenecid—Vomiting—Phenobarbital—epilepsy syndrome	0.000203	0.00219	CcSEcCtD
Probenecid—Urticaria—Acetazolamide—epilepsy syndrome	0.000202	0.00218	CcSEcCtD
Probenecid—Pain—Propofol—epilepsy syndrome	0.000202	0.00218	CcSEcCtD
Probenecid—Pruritus—Clobazam—epilepsy syndrome	0.000202	0.00218	CcSEcCtD
Probenecid—Anorexia—Diazepam—epilepsy syndrome	0.000202	0.00217	CcSEcCtD
Probenecid—Body temperature increased—Acetazolamide—epilepsy syndrome	0.000201	0.00217	CcSEcCtD
Probenecid—Dermatitis—Phenobarbital—epilepsy syndrome	0.000201	0.00217	CcSEcCtD
Probenecid—Leukopenia—Carbamazepine—epilepsy syndrome	0.000201	0.00216	CcSEcCtD
Probenecid—Anaemia—Lamotrigine—epilepsy syndrome	0.000201	0.00216	CcSEcCtD
Probenecid—ABCC3—nervous system—epilepsy syndrome	0.0002	0.00709	CbGeAlD
Probenecid—Headache—Phenobarbital—epilepsy syndrome	0.0002	0.00215	CcSEcCtD
Probenecid—Vomiting—Rufinamide—epilepsy syndrome	0.000199	0.00215	CcSEcCtD
Probenecid—Decreased appetite—Levetiracetam—epilepsy syndrome	0.000199	0.00214	CcSEcCtD
Probenecid—Pain—Midazolam—epilepsy syndrome	0.000198	0.00213	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Pregabalin—epilepsy syndrome	0.000198	0.00213	CcSEcCtD
Probenecid—Dermatitis—Rufinamide—epilepsy syndrome	0.000198	0.00213	CcSEcCtD
Probenecid—Headache—Rufinamide—epilepsy syndrome	0.000196	0.00211	CcSEcCtD
Probenecid—Pain—Levetiracetam—epilepsy syndrome	0.000196	0.0021	CcSEcCtD
Probenecid—Anorexia—Felbamate—epilepsy syndrome	0.000195	0.0021	CcSEcCtD
Probenecid—Dizziness—Lacosamide—epilepsy syndrome	0.000195	0.0021	CcSEcCtD
Probenecid—Leukopenia—Lamotrigine—epilepsy syndrome	0.000194	0.00209	CcSEcCtD
Probenecid—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.000193	0.00208	CcSEcCtD
Probenecid—ABCC3—central nervous system—epilepsy syndrome	0.000193	0.00683	CbGeAlD
Probenecid—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.000192	0.00207	CcSEcCtD
Probenecid—Decreased appetite—Fosphenytoin—epilepsy syndrome	0.000192	0.00206	CcSEcCtD
Probenecid—Anorexia—Zonisamide—epilepsy syndrome	0.000191	0.00206	CcSEcCtD
Probenecid—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.000191	0.00206	CcSEcCtD
Probenecid—Haematuria—Pregabalin—epilepsy syndrome	0.00019	0.00205	CcSEcCtD
Probenecid—Nausea—Phenobarbital—epilepsy syndrome	0.00019	0.00204	CcSEcCtD
Probenecid—Pollakiuria—Gabapentin—epilepsy syndrome	0.00019	0.00204	CcSEcCtD
Probenecid—Dizziness—Clobazam—epilepsy syndrome	0.000189	0.00203	CcSEcCtD
Probenecid—SLC22A1—head—epilepsy syndrome	0.000188	0.00667	CbGeAlD
Probenecid—Urticaria—Propofol—epilepsy syndrome	0.000188	0.00202	CcSEcCtD
Probenecid—Procainamide—SCN2A—epilepsy syndrome	0.000187	0.0489	CrCbGaD
Probenecid—Erythema multiforme—Valproic Acid—epilepsy syndrome	0.000187	0.00202	CcSEcCtD
Probenecid—Vomiting—Lacosamide—epilepsy syndrome	0.000187	0.00202	CcSEcCtD
Probenecid—Body temperature increased—Propofol—epilepsy syndrome	0.000187	0.00201	CcSEcCtD
Probenecid—Decreased appetite—Vigabatrin—epilepsy syndrome	0.000187	0.00201	CcSEcCtD
Probenecid—Nausea—Rufinamide—epilepsy syndrome	0.000186	0.002	CcSEcCtD
Probenecid—Dermatitis—Lacosamide—epilepsy syndrome	0.000186	0.002	CcSEcCtD
Probenecid—Headache—Lacosamide—epilepsy syndrome	0.000184	0.00199	CcSEcCtD
Probenecid—Anorexia—Clonazepam—epilepsy syndrome	0.000184	0.00198	CcSEcCtD
Probenecid—Decreased appetite—Diazepam—epilepsy syndrome	0.000184	0.00198	CcSEcCtD
Probenecid—Pain—Vigabatrin—epilepsy syndrome	0.000184	0.00198	CcSEcCtD
Probenecid—Urticaria—Midazolam—epilepsy syndrome	0.000184	0.00198	CcSEcCtD
Probenecid—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.000183	0.00197	CcSEcCtD
Probenecid—Anorexia—Phenytoin—epilepsy syndrome	0.000183	0.00197	CcSEcCtD
Probenecid—ABCC5—brain—epilepsy syndrome	0.000182	0.00646	CbGeAlD
Probenecid—Anorexia—Oxcarbazepine—epilepsy syndrome	0.000182	0.00196	CcSEcCtD
Probenecid—Vomiting—Clobazam—epilepsy syndrome	0.000182	0.00196	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Gabapentin—epilepsy syndrome	0.000181	0.00195	CcSEcCtD
Probenecid—SLCO1A2—head—epilepsy syndrome	0.000181	0.00642	CbGeAlD
Probenecid—Pain—Diazepam—epilepsy syndrome	0.000181	0.00195	CcSEcCtD
Probenecid—Body temperature increased—Levetiracetam—epilepsy syndrome	0.000181	0.00194	CcSEcCtD
Probenecid—Dermatitis—Clobazam—epilepsy syndrome	0.00018	0.00194	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Topiramate—epilepsy syndrome	0.00018	0.00194	CcSEcCtD
Probenecid—Headache—Clobazam—epilepsy syndrome	0.000179	0.00193	CcSEcCtD
Probenecid—SLC22A1—nervous system—epilepsy syndrome	0.000178	0.00632	CbGeAlD
Probenecid—Decreased appetite—Felbamate—epilepsy syndrome	0.000178	0.00192	CcSEcCtD
Probenecid—Urticaria—Fosphenytoin—epilepsy syndrome	0.000175	0.00189	CcSEcCtD
Probenecid—Pain—Felbamate—epilepsy syndrome	0.000175	0.00189	CcSEcCtD
Probenecid—Alopecia—Valproic Acid—epilepsy syndrome	0.000175	0.00188	CcSEcCtD
Probenecid—Nausea—Lacosamide—epilepsy syndrome	0.000175	0.00188	CcSEcCtD
Probenecid—Anorexia—Carbamazepine—epilepsy syndrome	0.000175	0.00188	CcSEcCtD
Probenecid—Haematuria—Gabapentin—epilepsy syndrome	0.000174	0.00188	CcSEcCtD
Probenecid—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.000174	0.00188	CcSEcCtD
Probenecid—Decreased appetite—Zonisamide—epilepsy syndrome	0.000174	0.00188	CcSEcCtD
Probenecid—ABCC4—head—epilepsy syndrome	0.000174	0.00618	CbGeAlD
Probenecid—Procaine—BCHE—epilepsy syndrome	0.000174	0.0455	CrCbGaD
Probenecid—SLC22A8—head—epilepsy syndrome	0.000173	0.00613	CbGeAlD
Probenecid—SLCO1A2—nervous system—epilepsy syndrome	0.000172	0.00608	CbGeAlD
Probenecid—SLC22A1—central nervous system—epilepsy syndrome	0.000172	0.00608	CbGeAlD
Probenecid—Urticaria—Vigabatrin—epilepsy syndrome	0.000171	0.00184	CcSEcCtD
Probenecid—Hypersensitivity—Midazolam—epilepsy syndrome	0.000171	0.00184	CcSEcCtD
Probenecid—Body temperature increased—Vigabatrin—epilepsy syndrome	0.00017	0.00183	CcSEcCtD
Probenecid—Nausea—Clobazam—epilepsy syndrome	0.00017	0.00183	CcSEcCtD
Probenecid—Erythema multiforme—Pregabalin—epilepsy syndrome	0.000169	0.00182	CcSEcCtD
Probenecid—Anorexia—Lamotrigine—epilepsy syndrome	0.000169	0.00182	CcSEcCtD
Probenecid—Dizziness—Acetazolamide—epilepsy syndrome	0.000168	0.00181	CcSEcCtD
Probenecid—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000168	0.00181	CcSEcCtD
Probenecid—Urticaria—Diazepam—epilepsy syndrome	0.000168	0.00181	CcSEcCtD
Probenecid—Decreased appetite—Clonazepam—epilepsy syndrome	0.000168	0.00181	CcSEcCtD
Probenecid—Pruritus—Propofol—epilepsy syndrome	0.000167	0.0018	CcSEcCtD
Probenecid—Decreased appetite—Phenytoin—epilepsy syndrome	0.000167	0.0018	CcSEcCtD
Probenecid—Flushing—Pregabalin—epilepsy syndrome	0.000166	0.00179	CcSEcCtD
Probenecid—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.000166	0.00179	CcSEcCtD
Probenecid—SLC16A1—brain—epilepsy syndrome	0.000166	0.00587	CbGeAlD
Probenecid—SLCO1A2—central nervous system—epilepsy syndrome	0.000165	0.00586	CbGeAlD
Probenecid—Pain—Clonazepam—epilepsy syndrome	0.000165	0.00178	CcSEcCtD
Probenecid—ABCC4—nervous system—epilepsy syndrome	0.000165	0.00586	CbGeAlD
Probenecid—SLC22A5—medulla oblongata—epilepsy syndrome	0.000165	0.00584	CbGeAlD
Probenecid—SLC22A8—nervous system—epilepsy syndrome	0.000164	0.00581	CbGeAlD
Probenecid—Pruritus—Midazolam—epilepsy syndrome	0.000164	0.00176	CcSEcCtD
Probenecid—Pain—Oxcarbazepine—epilepsy syndrome	0.000163	0.00176	CcSEcCtD
Probenecid—Urticaria—Felbamate—epilepsy syndrome	0.000163	0.00175	CcSEcCtD
Probenecid—Body temperature increased—Felbamate—epilepsy syndrome	0.000162	0.00174	CcSEcCtD
Probenecid—Vomiting—Acetazolamide—epilepsy syndrome	0.000162	0.00174	CcSEcCtD
Probenecid—Pruritus—Levetiracetam—epilepsy syndrome	0.000162	0.00174	CcSEcCtD
Probenecid—SLCO1A2—cerebellum—epilepsy syndrome	0.000162	0.00573	CbGeAlD
Probenecid—Headache—Acetazolamide—epilepsy syndrome	0.00016	0.00172	CcSEcCtD
Probenecid—Pollakiuria—Topiramate—epilepsy syndrome	0.000159	0.00172	CcSEcCtD
Probenecid—Anaemia—Valproic Acid—epilepsy syndrome	0.000159	0.00172	CcSEcCtD
Probenecid—Urticaria—Zonisamide—epilepsy syndrome	0.000159	0.00171	CcSEcCtD
Probenecid—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000159	0.00171	CcSEcCtD
Probenecid—ABCC4—central nervous system—epilepsy syndrome	0.000159	0.00564	CbGeAlD
Probenecid—Body temperature increased—Zonisamide—epilepsy syndrome	0.000159	0.00171	CcSEcCtD
Probenecid—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000158	0.00171	CcSEcCtD
Probenecid—Alopecia—Pregabalin—epilepsy syndrome	0.000158	0.0017	CcSEcCtD
Probenecid—SLC22A8—central nervous system—epilepsy syndrome	0.000158	0.00559	CbGeAlD
Probenecid—Pain—Carbamazepine—epilepsy syndrome	0.000157	0.00169	CcSEcCtD
Probenecid—Dizziness—Propofol—epilepsy syndrome	0.000156	0.00168	CcSEcCtD
Probenecid—Pruritus—Fosphenytoin—epilepsy syndrome	0.000156	0.00168	CcSEcCtD
Probenecid—Hypersensitivity—Diazepam—epilepsy syndrome	0.000156	0.00168	CcSEcCtD
Probenecid—Erythema multiforme—Gabapentin—epilepsy syndrome	0.000155	0.00167	CcSEcCtD
Probenecid—Leukopenia—Valproic Acid—epilepsy syndrome	0.000154	0.00166	CcSEcCtD
Probenecid—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000154	0.00166	CcSEcCtD
Probenecid—Urticaria—Clonazepam—epilepsy syndrome	0.000154	0.00165	CcSEcCtD
Probenecid—Dizziness—Midazolam—epilepsy syndrome	0.000153	0.00165	CcSEcCtD
Probenecid—ABCC3—brain—epilepsy syndrome	0.000153	0.00542	CbGeAlD
Probenecid—Body temperature increased—Clonazepam—epilepsy syndrome	0.000153	0.00164	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	0.000153	0.00164	CcSEcCtD
Probenecid—Urticaria—Phenytoin—epilepsy syndrome	0.000153	0.00164	CcSEcCtD
Probenecid—Pruritus—Vigabatrin—epilepsy syndrome	0.000152	0.00164	CcSEcCtD
Probenecid—Body temperature increased—Phenytoin—epilepsy syndrome	0.000152	0.00163	CcSEcCtD
Probenecid—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000152	0.00163	CcSEcCtD
Probenecid—Pain—Lamotrigine—epilepsy syndrome	0.000151	0.00163	CcSEcCtD
Probenecid—Nausea—Acetazolamide—epilepsy syndrome	0.000151	0.00163	CcSEcCtD
Probenecid—Dizziness—Levetiracetam—epilepsy syndrome	0.000151	0.00163	CcSEcCtD
Probenecid—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000151	0.00163	CcSEcCtD
Probenecid—SLC22A5—midbrain—epilepsy syndrome	0.000151	0.00534	CbGeAlD
Probenecid—Vomiting—Propofol—epilepsy syndrome	0.00015	0.00162	CcSEcCtD
Probenecid—Pruritus—Diazepam—epilepsy syndrome	0.00015	0.00161	CcSEcCtD
Probenecid—Dermatitis—Propofol—epilepsy syndrome	0.000149	0.0016	CcSEcCtD
Probenecid—Headache—Propofol—epilepsy syndrome	0.000148	0.0016	CcSEcCtD
Probenecid—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000148	0.00159	CcSEcCtD
Probenecid—Vomiting—Midazolam—epilepsy syndrome	0.000147	0.00158	CcSEcCtD
Probenecid—SLC22A5—spinal cord—epilepsy syndrome	0.000147	0.00521	CbGeAlD
Probenecid—Haematuria—Topiramate—epilepsy syndrome	0.000147	0.00158	CcSEcCtD
Probenecid—Dizziness—Fosphenytoin—epilepsy syndrome	0.000146	0.00157	CcSEcCtD
Probenecid—Dermatitis—Midazolam—epilepsy syndrome	0.000146	0.00157	CcSEcCtD
Probenecid—Urticaria—Carbamazepine—epilepsy syndrome	0.000146	0.00157	CcSEcCtD
Probenecid—Vomiting—Levetiracetam—epilepsy syndrome	0.000145	0.00156	CcSEcCtD
Probenecid—Alopecia—Gabapentin—epilepsy syndrome	0.000145	0.00156	CcSEcCtD
Probenecid—Headache—Midazolam—epilepsy syndrome	0.000145	0.00156	CcSEcCtD
Probenecid—Pruritus—Felbamate—epilepsy syndrome	0.000145	0.00156	CcSEcCtD
Probenecid—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000145	0.00156	CcSEcCtD
Probenecid—Anaemia—Pregabalin—epilepsy syndrome	0.000144	0.00155	CcSEcCtD
Probenecid—Dermatitis—Levetiracetam—epilepsy syndrome	0.000144	0.00155	CcSEcCtD
Probenecid—Headache—Levetiracetam—epilepsy syndrome	0.000143	0.00154	CcSEcCtD
Probenecid—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000142	0.00153	CcSEcCtD
Probenecid—Dizziness—Vigabatrin—epilepsy syndrome	0.000142	0.00153	CcSEcCtD
Probenecid—Pruritus—Zonisamide—epilepsy syndrome	0.000142	0.00153	CcSEcCtD
Probenecid—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000141	0.00152	CcSEcCtD
Probenecid—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000141	0.00151	CcSEcCtD
Probenecid—Urticaria—Lamotrigine—epilepsy syndrome	0.000141	0.00151	CcSEcCtD
Probenecid—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000141	0.00151	CcSEcCtD
Probenecid—Nausea—Propofol—epilepsy syndrome	0.000141	0.00151	CcSEcCtD
Probenecid—Vomiting—Fosphenytoin—epilepsy syndrome	0.00014	0.00151	CcSEcCtD
Probenecid—Body temperature increased—Lamotrigine—epilepsy syndrome	0.00014	0.00151	CcSEcCtD
Probenecid—Dizziness—Diazepam—epilepsy syndrome	0.00014	0.00151	CcSEcCtD
Probenecid—Leukopenia—Pregabalin—epilepsy syndrome	0.00014	0.0015	CcSEcCtD
Probenecid—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000139	0.0015	CcSEcCtD
Probenecid—Headache—Fosphenytoin—epilepsy syndrome	0.000138	0.00149	CcSEcCtD
Probenecid—Nausea—Midazolam—epilepsy syndrome	0.000138	0.00148	CcSEcCtD
Probenecid—Pruritus—Clonazepam—epilepsy syndrome	0.000137	0.00147	CcSEcCtD
Probenecid—Vomiting—Vigabatrin—epilepsy syndrome	0.000137	0.00147	CcSEcCtD
Probenecid—SLC22A1—brain—epilepsy syndrome	0.000136	0.00483	CbGeAlD
Probenecid—Pruritus—Phenytoin—epilepsy syndrome	0.000136	0.00146	CcSEcCtD
Probenecid—Nausea—Levetiracetam—epilepsy syndrome	0.000136	0.00146	CcSEcCtD
Probenecid—Dizziness—Felbamate—epilepsy syndrome	0.000136	0.00146	CcSEcCtD
Probenecid—Dermatitis—Vigabatrin—epilepsy syndrome	0.000135	0.00146	CcSEcCtD
Probenecid—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000135	0.00145	CcSEcCtD
Probenecid—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000135	0.00145	CcSEcCtD
Probenecid—Headache—Vigabatrin—epilepsy syndrome	0.000135	0.00145	CcSEcCtD
Probenecid—Vomiting—Diazepam—epilepsy syndrome	0.000135	0.00145	CcSEcCtD
Probenecid—Anorexia—Valproic Acid—epilepsy syndrome	0.000134	0.00144	CcSEcCtD
Probenecid—Dermatitis—Diazepam—epilepsy syndrome	0.000133	0.00144	CcSEcCtD
Probenecid—Dizziness—Zonisamide—epilepsy syndrome	0.000133	0.00143	CcSEcCtD
Probenecid—Headache—Diazepam—epilepsy syndrome	0.000133	0.00143	CcSEcCtD
Probenecid—ABCC1—cerebellum—epilepsy syndrome	0.000133	0.0047	CbGeAlD
Probenecid—Anaemia—Gabapentin—epilepsy syndrome	0.000132	0.00142	CcSEcCtD
Probenecid—SLCO1A2—brain—epilepsy syndrome	0.000131	0.00465	CbGeAlD
Probenecid—Nausea—Fosphenytoin—epilepsy syndrome	0.000131	0.00141	CcSEcCtD
Probenecid—Erythema multiforme—Topiramate—epilepsy syndrome	0.000131	0.00141	CcSEcCtD
Probenecid—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000131	0.0014	CcSEcCtD
Probenecid—ALB—brain—epilepsy syndrome	0.00013	0.00462	CbGeAlD
Probenecid—Vomiting—Felbamate—epilepsy syndrome	0.00013	0.0014	CcSEcCtD
Probenecid—Pruritus—Carbamazepine—epilepsy syndrome	0.00013	0.0014	CcSEcCtD
Probenecid—Dermatitis—Felbamate—epilepsy syndrome	0.000129	0.00139	CcSEcCtD
Probenecid—Headache—Felbamate—epilepsy syndrome	0.000128	0.00138	CcSEcCtD
Probenecid—Flushing—Topiramate—epilepsy syndrome	0.000128	0.00138	CcSEcCtD
Probenecid—Leukopenia—Gabapentin—epilepsy syndrome	0.000128	0.00138	CcSEcCtD
Probenecid—Dizziness—Clonazepam—epilepsy syndrome	0.000128	0.00138	CcSEcCtD
Probenecid—Nausea—Vigabatrin—epilepsy syndrome	0.000128	0.00137	CcSEcCtD
Probenecid—Vomiting—Zonisamide—epilepsy syndrome	0.000128	0.00137	CcSEcCtD
Probenecid—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000127	0.00137	CcSEcCtD
Probenecid—Dizziness—Phenytoin—epilepsy syndrome	0.000127	0.00137	CcSEcCtD
Probenecid—Dermatitis—Zonisamide—epilepsy syndrome	0.000126	0.00136	CcSEcCtD
Probenecid—ABCC4—brain—epilepsy syndrome	0.000126	0.00448	CbGeAlD
Probenecid—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000126	0.00136	CcSEcCtD
Probenecid—Nausea—Diazepam—epilepsy syndrome	0.000126	0.00135	CcSEcCtD
Probenecid—Headache—Zonisamide—epilepsy syndrome	0.000126	0.00135	CcSEcCtD
Probenecid—Pruritus—Lamotrigine—epilepsy syndrome	0.000125	0.00135	CcSEcCtD
Probenecid—SLC22A8—brain—epilepsy syndrome	0.000125	0.00444	CbGeAlD
Probenecid—Vomiting—Clonazepam—epilepsy syndrome	0.000123	0.00132	CcSEcCtD
Probenecid—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000122	0.00132	CcSEcCtD
Probenecid—Alopecia—Topiramate—epilepsy syndrome	0.000122	0.00131	CcSEcCtD
Probenecid—Vomiting—Phenytoin—epilepsy syndrome	0.000122	0.00131	CcSEcCtD
Probenecid—Dermatitis—Clonazepam—epilepsy syndrome	0.000122	0.00131	CcSEcCtD
Probenecid—Nausea—Felbamate—epilepsy syndrome	0.000122	0.00131	CcSEcCtD
Probenecid—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000121	0.00131	CcSEcCtD
Probenecid—Anorexia—Pregabalin—epilepsy syndrome	0.000121	0.00131	CcSEcCtD
Probenecid—Dizziness—Carbamazepine—epilepsy syndrome	0.000121	0.0013	CcSEcCtD
Probenecid—Headache—Clonazepam—epilepsy syndrome	0.000121	0.0013	CcSEcCtD
Probenecid—Dermatitis—Phenytoin—epilepsy syndrome	0.000121	0.0013	CcSEcCtD
Probenecid—Pain—Valproic Acid—epilepsy syndrome	0.00012	0.0013	CcSEcCtD
Probenecid—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.00012	0.00129	CcSEcCtD
Probenecid—Headache—Phenytoin—epilepsy syndrome	0.00012	0.00129	CcSEcCtD
Probenecid—Headache—Oxcarbazepine—epilepsy syndrome	0.00012	0.00129	CcSEcCtD
Probenecid—Nausea—Zonisamide—epilepsy syndrome	0.000119	0.00128	CcSEcCtD
Probenecid—Dizziness—Lamotrigine—epilepsy syndrome	0.000117	0.00126	CcSEcCtD
Probenecid—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000117	0.00126	CcSEcCtD
Probenecid—SLC22A5—cerebellum—epilepsy syndrome	0.000117	0.00413	CbGeAlD
Probenecid—Vomiting—Carbamazepine—epilepsy syndrome	0.000117	0.00125	CcSEcCtD
Probenecid—Dermatitis—Carbamazepine—epilepsy syndrome	0.000115	0.00124	CcSEcCtD
Probenecid—Nausea—Clonazepam—epilepsy syndrome	0.000115	0.00124	CcSEcCtD
Probenecid—Headache—Carbamazepine—epilepsy syndrome	0.000115	0.00124	CcSEcCtD
Probenecid—Nausea—Phenytoin—epilepsy syndrome	0.000114	0.00123	CcSEcCtD
Probenecid—Nausea—Oxcarbazepine—epilepsy syndrome	0.000113	0.00122	CcSEcCtD
Probenecid—Vomiting—Lamotrigine—epilepsy syndrome	0.000113	0.00121	CcSEcCtD
Probenecid—Urticaria—Valproic Acid—epilepsy syndrome	0.000112	0.0012	CcSEcCtD
Probenecid—Dermatitis—Lamotrigine—epilepsy syndrome	0.000112	0.0012	CcSEcCtD
Probenecid—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000111	0.0012	CcSEcCtD
Probenecid—Anorexia—Gabapentin—epilepsy syndrome	0.000111	0.0012	CcSEcCtD
Probenecid—Anaemia—Topiramate—epilepsy syndrome	0.000111	0.0012	CcSEcCtD
Probenecid—Headache—Lamotrigine—epilepsy syndrome	0.000111	0.00119	CcSEcCtD
Probenecid—Decreased appetite—Pregabalin—epilepsy syndrome	0.000111	0.00119	CcSEcCtD
Probenecid—Nausea—Carbamazepine—epilepsy syndrome	0.000109	0.00117	CcSEcCtD
Probenecid—Pain—Pregabalin—epilepsy syndrome	0.000109	0.00117	CcSEcCtD
Probenecid—Procainamide—CHRM2—epilepsy syndrome	0.000108	0.0282	CrCbGaD
Probenecid—ABCC1—brain—epilepsy syndrome	0.000108	0.00382	CbGeAlD
Probenecid—Leukopenia—Topiramate—epilepsy syndrome	0.000108	0.00116	CcSEcCtD
Probenecid—ABCB1—forebrain—epilepsy syndrome	0.000106	0.00375	CbGeAlD
Probenecid—Nausea—Lamotrigine—epilepsy syndrome	0.000105	0.00113	CcSEcCtD
Probenecid—Chlorpropamide—CYP2C19—epilepsy syndrome	0.000105	0.0274	CrCbGaD
Probenecid—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000104	0.00112	CcSEcCtD
Probenecid—Tolbutamide—CYP2C19—epilepsy syndrome	0.000102	0.0267	CrCbGaD
Probenecid—Decreased appetite—Gabapentin—epilepsy syndrome	0.000101	0.00109	CcSEcCtD
Probenecid—Urticaria—Pregabalin—epilepsy syndrome	0.000101	0.00109	CcSEcCtD
Probenecid—Body temperature increased—Pregabalin—epilepsy syndrome	0.000101	0.00108	CcSEcCtD
Probenecid—Pain—Gabapentin—epilepsy syndrome	9.98e-05	0.00107	CcSEcCtD
Probenecid—Pruritus—Valproic Acid—epilepsy syndrome	9.96e-05	0.00107	CcSEcCtD
Probenecid—ABCB1—telencephalon—epilepsy syndrome	9.74e-05	0.00345	CbGeAlD
Probenecid—SLC22A5—brain—epilepsy syndrome	9.47e-05	0.00336	CbGeAlD
Probenecid—Hypersensitivity—Pregabalin—epilepsy syndrome	9.38e-05	0.00101	CcSEcCtD
Probenecid—Anorexia—Topiramate—epilepsy syndrome	9.36e-05	0.00101	CcSEcCtD
Probenecid—Dizziness—Valproic Acid—epilepsy syndrome	9.31e-05	0.001	CcSEcCtD
Probenecid—Urticaria—Gabapentin—epilepsy syndrome	9.27e-05	0.000998	CcSEcCtD
Probenecid—Body temperature increased—Gabapentin—epilepsy syndrome	9.23e-05	0.000993	CcSEcCtD
Probenecid—CYP2C8—brain—epilepsy syndrome	9.17e-05	0.00325	CbGeAlD
Probenecid—Procainamide—BCHE—epilepsy syndrome	9.02e-05	0.0235	CrCbGaD
Probenecid—Pruritus—Pregabalin—epilepsy syndrome	9e-05	0.000969	CcSEcCtD
Probenecid—Vomiting—Valproic Acid—epilepsy syndrome	8.95e-05	0.000963	CcSEcCtD
Probenecid—Dermatitis—Valproic Acid—epilepsy syndrome	8.87e-05	0.000954	CcSEcCtD
Probenecid—Headache—Valproic Acid—epilepsy syndrome	8.82e-05	0.000949	CcSEcCtD
Probenecid—Hypersensitivity—Gabapentin—epilepsy syndrome	8.6e-05	0.000925	CcSEcCtD
Probenecid—Decreased appetite—Topiramate—epilepsy syndrome	8.54e-05	0.000919	CcSEcCtD
Probenecid—Dizziness—Pregabalin—epilepsy syndrome	8.42e-05	0.000906	CcSEcCtD
Probenecid—Pain—Topiramate—epilepsy syndrome	8.4e-05	0.000904	CcSEcCtD
Probenecid—Nausea—Valproic Acid—epilepsy syndrome	8.36e-05	0.0009	CcSEcCtD
Probenecid—Pruritus—Gabapentin—epilepsy syndrome	8.26e-05	0.000889	CcSEcCtD
Probenecid—CYP3A4—nervous system—epilepsy syndrome	8.13e-05	0.00288	CbGeAlD
Probenecid—Vomiting—Pregabalin—epilepsy syndrome	8.09e-05	0.000871	CcSEcCtD
Probenecid—Dermatitis—Pregabalin—epilepsy syndrome	8.02e-05	0.000863	CcSEcCtD
Probenecid—Headache—Pregabalin—epilepsy syndrome	7.97e-05	0.000858	CcSEcCtD
Probenecid—CYP3A4—central nervous system—epilepsy syndrome	7.82e-05	0.00277	CbGeAlD
Probenecid—Urticaria—Topiramate—epilepsy syndrome	7.8e-05	0.000839	CcSEcCtD
Probenecid—Body temperature increased—Topiramate—epilepsy syndrome	7.76e-05	0.000835	CcSEcCtD
Probenecid—Dizziness—Gabapentin—epilepsy syndrome	7.72e-05	0.000831	CcSEcCtD
Probenecid—ABCB1—medulla oblongata—epilepsy syndrome	7.66e-05	0.00271	CbGeAlD
Probenecid—Nausea—Pregabalin—epilepsy syndrome	7.56e-05	0.000814	CcSEcCtD
Probenecid—Vomiting—Gabapentin—epilepsy syndrome	7.42e-05	0.000799	CcSEcCtD
Probenecid—Dermatitis—Gabapentin—epilepsy syndrome	7.35e-05	0.000791	CcSEcCtD
Probenecid—Headache—Gabapentin—epilepsy syndrome	7.31e-05	0.000787	CcSEcCtD
Probenecid—Hypersensitivity—Topiramate—epilepsy syndrome	7.23e-05	0.000778	CcSEcCtD
Probenecid—ABCB1—midbrain—epilepsy syndrome	7e-05	0.00248	CbGeAlD
Probenecid—Pruritus—Topiramate—epilepsy syndrome	6.95e-05	0.000748	CcSEcCtD
Probenecid—Nausea—Gabapentin—epilepsy syndrome	6.93e-05	0.000746	CcSEcCtD
Probenecid—ABCB1—spinal cord—epilepsy syndrome	6.83e-05	0.00242	CbGeAlD
Probenecid—Dizziness—Topiramate—epilepsy syndrome	6.49e-05	0.000699	CcSEcCtD
Probenecid—Vomiting—Topiramate—epilepsy syndrome	6.24e-05	0.000672	CcSEcCtD
Probenecid—Dermatitis—Topiramate—epilepsy syndrome	6.18e-05	0.000666	CcSEcCtD
Probenecid—Headache—Topiramate—epilepsy syndrome	6.15e-05	0.000662	CcSEcCtD
Probenecid—ABCB1—head—epilepsy syndrome	6.07e-05	0.00215	CbGeAlD
Probenecid—Nausea—Topiramate—epilepsy syndrome	5.83e-05	0.000628	CcSEcCtD
Probenecid—ABCB1—nervous system—epilepsy syndrome	5.75e-05	0.00204	CbGeAlD
Probenecid—Chlorpropamide—ABCB1—epilepsy syndrome	5.57e-05	0.0145	CrCbGaD
Probenecid—ABCB1—central nervous system—epilepsy syndrome	5.54e-05	0.00196	CbGeAlD
Probenecid—ABCB1—cerebellum—epilepsy syndrome	5.41e-05	0.00192	CbGeAlD
Probenecid—Procainamide—CYP2D6—epilepsy syndrome	4.95e-05	0.0129	CrCbGaD
Probenecid—ABCB1—brain—epilepsy syndrome	4.4e-05	0.00156	CbGeAlD
Probenecid—SLC22A1—Metabolism—BCHE—epilepsy syndrome	2.45e-06	2.55e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	2.44e-06	2.54e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	2.44e-06	2.54e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CHRM3—epilepsy syndrome	2.42e-06	2.53e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—KCNJ11—epilepsy syndrome	2.42e-06	2.53e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	2.42e-06	2.52e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	2.42e-06	2.52e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—AQP1—epilepsy syndrome	2.41e-06	2.51e-05	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.4e-06	2.51e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	2.39e-06	2.49e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PFKL—epilepsy syndrome	2.39e-06	2.49e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	2.39e-06	2.49e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	2.39e-06	2.49e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	2.39e-06	2.49e-05	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.38e-06	2.48e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—CCR5—epilepsy syndrome	2.38e-06	2.48e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—HMOX1—epilepsy syndrome	2.37e-06	2.47e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—AGT—epilepsy syndrome	2.36e-06	2.46e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—AQP1—epilepsy syndrome	2.35e-06	2.45e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—GPX1—epilepsy syndrome	2.35e-06	2.45e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—SLC2A1—epilepsy syndrome	2.34e-06	2.43e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—CAT—epilepsy syndrome	2.33e-06	2.43e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—APOE—epilepsy syndrome	2.32e-06	2.41e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.31e-06	2.41e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PLCB1—epilepsy syndrome	2.31e-06	2.41e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—TH—epilepsy syndrome	2.3e-06	2.4e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PRKCB—epilepsy syndrome	2.29e-06	2.39e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—ALB—epilepsy syndrome	2.29e-06	2.38e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—ABCB1—epilepsy syndrome	2.27e-06	2.37e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.27e-06	2.37e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—NOS2—epilepsy syndrome	2.26e-06	2.36e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	2.26e-06	2.36e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.26e-06	2.35e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.22e-06	2.32e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—TSC2—epilepsy syndrome	2.21e-06	2.31e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.21e-06	2.31e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—AQP1—epilepsy syndrome	2.19e-06	2.29e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ATIC—epilepsy syndrome	2.18e-06	2.28e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—UPB1—epilepsy syndrome	2.18e-06	2.28e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NEU1—epilepsy syndrome	2.18e-06	2.28e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	2.18e-06	2.27e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	2.18e-06	2.27e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—APOE—epilepsy syndrome	2.17e-06	2.26e-05	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PTGS2—epilepsy syndrome	2.15e-06	2.24e-05	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.15e-06	2.24e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CHRM3—epilepsy syndrome	2.12e-06	2.21e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	2.12e-06	2.21e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—GPX1—epilepsy syndrome	2.11e-06	2.2e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.11e-06	2.2e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.1e-06	2.19e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—SRC—epilepsy syndrome	2.08e-06	2.17e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—HMOX1—epilepsy syndrome	2.06e-06	2.15e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—AGT—epilepsy syndrome	2.06e-06	2.14e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—IL6ST—epilepsy syndrome	2.03e-06	2.12e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—CAT—epilepsy syndrome	2.03e-06	2.12e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.03e-06	2.12e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.03e-06	2.12e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.03e-06	2.11e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—NOS2—epilepsy syndrome	2.02e-06	2.1e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—APOE—epilepsy syndrome	2.02e-06	2.1e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PTGS2—epilepsy syndrome	2e-06	2.09e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—POMC—epilepsy syndrome	1.99e-06	2.07e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	1.99e-06	2.07e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.99e-06	2.07e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	1.98e-06	2.07e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	1.98e-06	2.07e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—ABCB1—epilepsy syndrome	1.98e-06	2.06e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—ABCG2—epilepsy syndrome	1.98e-06	2.06e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	1.94e-06	2.02e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CYP2C19—epilepsy syndrome	1.93e-06	2.01e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	1.92e-06	2.01e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—HMOX1—epilepsy syndrome	1.92e-06	2e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CYP11A1—epilepsy syndrome	1.91e-06	1.99e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.91e-06	1.99e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.91e-06	1.99e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.9e-06	1.98e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—CAT—epilepsy syndrome	1.9e-06	1.98e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.86e-06	1.94e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—AGT—epilepsy syndrome	1.85e-06	1.93e-05	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—AKT1—epilepsy syndrome	1.85e-06	1.93e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.85e-06	1.93e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—ABCB1—epilepsy syndrome	1.84e-06	1.92e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—GPX1—epilepsy syndrome	1.84e-06	1.92e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—APOE—epilepsy syndrome	1.81e-06	1.89e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—ALB—epilepsy syndrome	1.81e-06	1.89e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.81e-06	1.89e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.81e-06	1.89e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.81e-06	1.89e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	1.77e-06	1.85e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.74e-06	1.82e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	1.74e-06	1.81e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—POMC—epilepsy syndrome	1.73e-06	1.81e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ABCG2—epilepsy syndrome	1.73e-06	1.8e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CYP2D6—epilepsy syndrome	1.73e-06	1.8e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.73e-06	1.8e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.73e-06	1.8e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	1.72e-06	1.79e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—GPX1—epilepsy syndrome	1.71e-06	1.79e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.71e-06	1.78e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.69e-06	1.76e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	1.69e-06	1.76e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	1.68e-06	1.75e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.66e-06	1.73e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	1.65e-06	1.72e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—BCHE—epilepsy syndrome	1.65e-06	1.72e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—FGF2—epilepsy syndrome	1.65e-06	1.72e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—ADRA2A—epilepsy syndrome	1.64e-06	1.71e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—BCHE—epilepsy syndrome	1.64e-06	1.71e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.62e-06	1.69e-05	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	1.62e-06	1.69e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.62e-06	1.69e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—AGT—epilepsy syndrome	1.61e-06	1.68e-05	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.6e-06	1.67e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.59e-06	1.66e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PTGS2—epilepsy syndrome	1.59e-06	1.65e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—APOE—epilepsy syndrome	1.58e-06	1.65e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—ALB—epilepsy syndrome	1.58e-06	1.65e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	1.58e-06	1.64e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	1.57e-06	1.64e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	1.57e-06	1.63e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—SLC2A1—epilepsy syndrome	1.56e-06	1.63e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—POMC—epilepsy syndrome	1.56e-06	1.62e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.56e-06	1.62e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.56e-06	1.62e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	1.55e-06	1.62e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	1.55e-06	1.62e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—TH—epilepsy syndrome	1.55e-06	1.61e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PLCB1—epilepsy syndrome	1.55e-06	1.61e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—TH—epilepsy syndrome	1.54e-06	1.6e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.52e-06	1.59e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.52e-06	1.58e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1.51e-06	1.58e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—AGT—epilepsy syndrome	1.5e-06	1.57e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MTOR—epilepsy syndrome	1.5e-06	1.56e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.49e-06	1.55e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PTGS2—epilepsy syndrome	1.48e-06	1.55e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.48e-06	1.54e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—APOE—epilepsy syndrome	1.47e-06	1.53e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.47e-06	1.53e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.45e-06	1.51e-05	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.44e-06	1.5e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	1.44e-06	1.5e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—BCHE—epilepsy syndrome	1.43e-06	1.5e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—ALB—epilepsy syndrome	1.42e-06	1.48e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.42e-06	1.48e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	1.41e-06	1.47e-05	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—AKT1—epilepsy syndrome	1.41e-06	1.47e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.4e-06	1.46e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.39e-06	1.45e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—TH—epilepsy syndrome	1.38e-06	1.44e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PTGS2—epilepsy syndrome	1.38e-06	1.44e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	1.37e-06	1.43e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.36e-06	1.42e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—POMC—epilepsy syndrome	1.36e-06	1.41e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.35e-06	1.41e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—TH—epilepsy syndrome	1.35e-06	1.41e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—SRC—epilepsy syndrome	1.35e-06	1.4e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.35e-06	1.4e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.34e-06	1.4e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—VEGFA—epilepsy syndrome	1.31e-06	1.37e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.31e-06	1.36e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.31e-06	1.36e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	1.29e-06	1.35e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—AKT1—epilepsy syndrome	1.29e-06	1.35e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—HMOX1—epilepsy syndrome	1.28e-06	1.34e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.28e-06	1.33e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CAT—epilepsy syndrome	1.28e-06	1.33e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CAT—epilepsy syndrome	1.27e-06	1.32e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—POMC—epilepsy syndrome	1.27e-06	1.32e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.26e-06	1.32e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—TH—epilepsy syndrome	1.26e-06	1.31e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PTGS2—epilepsy syndrome	1.24e-06	1.3e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.24e-06	1.29e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	1.24e-06	1.29e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—ALB—epilepsy syndrome	1.24e-06	1.29e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—ABCB1—epilepsy syndrome	1.23e-06	1.29e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—SRC—epilepsy syndrome	1.2e-06	1.25e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.15e-06	1.2e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—ALB—epilepsy syndrome	1.15e-06	1.2e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GPX1—epilepsy syndrome	1.15e-06	1.2e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GPX1—epilepsy syndrome	1.15e-06	1.2e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.14e-06	1.19e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.13e-06	1.17e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CAT—epilepsy syndrome	1.11e-06	1.16e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.11e-06	1.15e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PTGS2—epilepsy syndrome	1.08e-06	1.13e-05	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—AKT1—epilepsy syndrome	1.08e-06	1.13e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.07e-06	1.11e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.05e-06	1.1e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.04e-06	1.08e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.04e-06	1.08e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.03e-06	1.08e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.03e-06	1.07e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—AGT—epilepsy syndrome	1.01e-06	1.05e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.01e-06	1.05e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PTGS2—epilepsy syndrome	1.01e-06	1.05e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—AKT1—epilepsy syndrome	1.01e-06	1.05e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—AGT—epilepsy syndrome	1.01e-06	1.05e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GPX1—epilepsy syndrome	1e-06	1.05e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—APOE—epilepsy syndrome	9.91e-07	1.03e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—APOE—epilepsy syndrome	9.85e-07	1.03e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GPX1—epilepsy syndrome	9.38e-07	9.78e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	9.32e-07	9.72e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—AGT—epilepsy syndrome	9.03e-07	9.41e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	8.88e-07	9.25e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—APOE—epilepsy syndrome	8.84e-07	9.22e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—BCHE—epilepsy syndrome	8.84e-07	9.21e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—AGT—epilepsy syndrome	8.81e-07	9.18e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—APOE—epilepsy syndrome	8.63e-07	9e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—POMC—epilepsy syndrome	8.51e-07	8.87e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—POMC—epilepsy syndrome	8.46e-07	8.82e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	8.43e-07	8.79e-06	CbGpPWpGaD
Probenecid—ALB—Hemostasis—AKT1—epilepsy syndrome	8.37e-07	8.72e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	8.34e-07	8.69e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—TH—epilepsy syndrome	8.31e-07	8.66e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—AGT—epilepsy syndrome	8.23e-07	8.58e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—APOE—epilepsy syndrome	8.06e-07	8.4e-06	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—AKT1—epilepsy syndrome	7.97e-07	8.31e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ALB—epilepsy syndrome	7.76e-07	8.09e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—POMC—epilepsy syndrome	7.6e-07	7.92e-06	CbGpPWpGaD
Probenecid—ABCC1—Disease—AKT1—epilepsy syndrome	7.46e-07	7.78e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—POMC—epilepsy syndrome	7.41e-07	7.73e-06	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—AKT1—epilepsy syndrome	6.94e-07	7.24e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	6.94e-07	7.23e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—POMC—epilepsy syndrome	6.93e-07	7.22e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ALB—epilepsy syndrome	6.93e-07	7.22e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CAT—epilepsy syndrome	6.84e-07	7.13e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	6.79e-07	7.08e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ALB—epilepsy syndrome	6.76e-07	7.05e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTGS2—epilepsy syndrome	6.75e-07	7.04e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	6.66e-07	6.94e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ALB—epilepsy syndrome	6.32e-07	6.58e-06	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—AKT1—epilepsy syndrome	6.25e-07	6.51e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GPX1—epilepsy syndrome	6.19e-07	6.45e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	6.06e-07	6.32e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTGS2—epilepsy syndrome	5.91e-07	6.16e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	5.52e-07	5.76e-06	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—AKT1—epilepsy syndrome	5.44e-07	5.67e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AGT—epilepsy syndrome	5.43e-07	5.66e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—APOE—epilepsy syndrome	5.32e-07	5.54e-06	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—AKT1—epilepsy syndrome	5.07e-07	5.29e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—POMC—epilepsy syndrome	4.57e-07	4.76e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ALB—epilepsy syndrome	4.16e-07	4.34e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	3.64e-07	3.8e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—AKT1—epilepsy syndrome	3.41e-07	3.56e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—AKT1—epilepsy syndrome	3.39e-07	3.54e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—AKT1—epilepsy syndrome	3.05e-07	3.17e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—AKT1—epilepsy syndrome	2.97e-07	3.1e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—AKT1—epilepsy syndrome	2.78e-07	2.89e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.83e-07	1.91e-06	CbGpPWpGaD
